Literature DB >> 6378353

Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.

G Mendelsohn, S A Wells, S B Baylin.   

Abstract

The distribution of carcinoembryonic antigen (CEA) and its relationship to calcitonin in early, localized, and disseminated (virulent) medullary thyroid carcinoma (MTC) have been studied using immunoperoxidase methods. Carcinoembryonic antigen can be demonstrated within C-cells through all stages of progression of MTC. In early disease (C-cell hyperplasia and microscopic carcinoma), CEA, and calcitonin have a similar distribution, being present in virtually every cell. Likewise, calcitonin and CEA have a similar, homogeneous distribution among cells in gross medullary carcinoma confined to the thyroid region. In both primary and metastatic tumors from patients with virulent, disseminated disease there is an inverse relationship between calcitonin and CEA distribution such that CEA expression is retained and frequently present in the greatest amounts in cells which have poor or absent staining for calcitonin, and present in the least amounts where cellular staining for calcitonin is greatest. It is postulated that in MTC expression of CEA (a marker for early epithelial differentiation), in the face of loss of calcitonin (a marker for terminal differentiation/cellular maturity), may reflect a degree of maturation block in tumors from patients with aggressive disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378353     DOI: 10.1002/1097-0142(1984)54:4<657::aid-cncr2820540412>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker.

Authors:  Shaohua Zhan; Jinming Li; Tianxiao Wang; Wei Ge
Journal:  Oncologist       Date:  2018-05-08

2.  Ultrastructural study of poorly differentiated medullary carcinoma of the thyroid.

Authors:  K Kakudo; A Miyauchi; S Katayama; K Watanabe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients.

Authors:  H Takami; T Bessho; T Kameya; T Mimura; K Ito; O Abe; Y Hosoda; J Shikata
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 4.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 5.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

6.  Fatal sporadic medullary carcinoma of the thyroid.

Authors:  H Ruben Harach; Ulla Bergholm
Journal:  Endocr Pathol       Date:  1993-03       Impact factor: 3.943

7.  Markov model-based estimation of individual survival probability for medullary thyroid cancer patients.

Authors:  Olga Esik; Gábor Tusnády; Lajos Trón; András Boér; Zoltán Szentirmay; István Szabolcs; Károly Rácz; Erzsébet Lengyel; Judit Székely; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

8.  Relationship of CD15 immunoreactivity and prognosis in sporadic medullary thyroid carcinoma.

Authors:  N Neuhold; F Längle; M Gnant; U Hollenstein; B Niederle
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Medullary thyroid carcinoma with micronodular lung metastases: a case report with an emphasis on the imaging findings.

Authors:  Nina Ventura; Edson Marchiori; Gláucia Zanetti; Antonio Muccillo; Mariana Leite Pereira; Guilherme Abdalla; Pedro Martins; Carolina Lamas Constantino; Rodrigo Canellas; Viviane Brandão; Romulo Varella de Oliveira
Journal:  Case Rep Med       Date:  2010-05-17

10.  Prognostic and predictive markers in medullary thyroid carcinoma.

Authors:  Boban M Erovic; Dae Kim; Clarissa Cassol; David P Goldstein; Jonathan C Irish; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2012-12       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.